ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Evaxion Biotech AS

Evaxion Biotech AS (EVAX)

3.39
0.00
(0.00%)
Cerrado 30 Enero 3:00PM
0.00
0.00
(0.00%)
Fuera de horario: -

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
3.39
Postura de Compra
3.27
Postura de Venta
3.33
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Capitalización de Mercado [m]
Precio Anterior
3.39
Precio de Apertura
-
Hora
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
-
Acciones en circulación
2,701,380
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
0.00
Beneficio por acción (BPA)
-
turnover
507k
Beneficio neto
-152.41M

Acerca de Evaxion Biotech AS

Evaxion Biotech AS is an artificial intelligence immunology platform company. It uses proprietary AI technology, engineering expertise, and drug development know-how to simulate the human immune system and generate predictive models to identify and develop efficacious immunotherapies for patients in... Evaxion Biotech AS is an artificial intelligence immunology platform company. It uses proprietary AI technology, engineering expertise, and drug development know-how to simulate the human immune system and generate predictive models to identify and develop efficacious immunotherapies for patients in the global market. Its two lead product candidates are EVX-01 and EVX-02, for the treatment of various cancers. Mostrar más

Sector
Biological Pds,ex Diagnstics
Industria
Biological Pds,ex Diagnstics
Sede
Horsholm, Dnk
Fundado
-
Evaxion Biotech AS is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker EVAX. The last closing price for Evaxion Biotech AS was US$3.39. Over the last year, Evaxion Biotech AS shares have traded in a share price range of US$ 0.00 to US$ 0.00.

Evaxion Biotech AS currently has 2,701,380 shares in issue. The market capitalisation of Evaxion Biotech AS is US$9.16 million.

EVAX Últimas noticias

Evaxion granted 180-day compliance extension by Nasdaq as it restores equity above minimum requirement

Following a constructive Nasdaq hearing panel on January 7, 2025, Evaxion has been granted a 180-day extension in relation to the Nasdaq minimum equity requirementEvaxion has currently restored...

Evaxion completes dosing in phase 2 trial with personalized cancer vaccine EVX-01

Trial remains on track for completion and data readout in the second half of 2025 COPENHAGEN, Denmark, January 15, 2025 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio...

Evaxion announces completion of ADS ratio change

COPENHAGEN, Denmark, January 14, 2025 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

EVAX - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Evaxion Biotech AS?
El precio actual de las acciones de Evaxion Biotech AS es US$ 3.39
¿Cuántas acciones de Evaxion Biotech AS están en circulación?
Evaxion Biotech AS tiene 2,701,380 acciones en circulación
¿Cuál es la capitalización de mercado de Evaxion Biotech AS?
La capitalización de mercado de Evaxion Biotech AS es USD 9.16M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Evaxion Biotech AS?
Evaxion Biotech AS ha negociado en un rango de US$ 0.00 a US$ 0.00 durante el último año
¿Cuál es la moneda de reporte de Evaxion Biotech AS?
Evaxion Biotech AS presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Evaxion Biotech AS?
El último ingresos anual de Evaxion Biotech AS es USD 507k
¿Cuál es el último beneficio anual de Evaxion Biotech AS?
El último beneficio anual de Evaxion Biotech AS es USD -152.41M
¿Cuál es la dirección registrada de Evaxion Biotech AS?
La dirección registrada de Evaxion Biotech AS es DR. NEERGAARDS VEJ 5F, HORSHOLM, 2970
¿Cuál es la dirección del sitio web de Evaxion Biotech AS?
La dirección del sitio web de Evaxion Biotech AS es www.evaxion-biotech.com
¿En qué sector industrial opera Evaxion Biotech AS?
Evaxion Biotech AS opera en el sector BIOLOGICAL PDS,EX DIAGNSTICS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
AALAmerican Airlines Group Inc
US$ 17.33
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 74.435
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.89
(0.00%)
0
AACGATA Creativity Global
US$ 0.8559
(0.00%)
0
AALAmerican Airlines Group Inc
US$ 17.33
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 74.435
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.89
(0.00%)
0
AACGATA Creativity Global
US$ 0.8559
(0.00%)
0
AALAmerican Airlines Group Inc
US$ 17.33
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 74.435
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.89
(0.00%)
0
AACGATA Creativity Global
US$ 0.8559
(0.00%)
0

EVAX Discussion

Ver más
BooDog BooDog 2 días hace
yeah, a 1M float will do this. $11pm one day and then down she goes.
👍️0
subslover subslover 6 días hace
Currently $11 😙
👍️0
glenn1919 glenn1919 6 días hace
EVAX.........................https://stockcharts.com/h-sc/ui?s=EVAX&p=W&b=5&g=0&id=p86431144783
👍️0
tw0122 tw0122 6 días hace
At $4s now $14s not long ago 
👍️0
subslover subslover 6 días hace
$6.02 having a convulsion
👍️0
glenn1919 glenn1919 1 mes hace
evax.....................https://stockcharts.com/h-sc/ui?s=evax&p=W&b=5&g=0&id=p86431144783
👍️0
subslover subslover 1 mes hace
PROXY out https://www.otcmarkets.com/filing/html?id=18071025&guid=lKY-kHdxdv3Th3h
👍️0
subslover subslover 1 mes hace
Was once a high-flying ticket.
👍️0
glenn1919 glenn1919 1 mes hace
EVAX....................https://stockcharts.com/h-sc/ui?s=EVAX&p=W&b=5&g=0&id=p86431144783
👍️0
tw0122 tw0122 1 mes hace
$2.04 + 120% looks good $14 looked best lol
👍️0
tw0122 tw0122 1 mes hace
$1.90
👍️0
tw0122 tw0122 1 mes hace
Hot off the presses $1.64 + 83%
👍️0
glenn1919 glenn1919 2 meses hace
EVAX.....................https://stockcharts.com/h-sc/ui?s=EVAX&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 3 meses hace
EVAX under $3
👍️0
Monksdream Monksdream 6 meses hace
EVAX under $3
👍️0
Monksdream Monksdream 6 meses hace
EVAX under $3
👍️0
Monksdream Monksdream 7 meses hace
EVAX under $5
👍️0
Monksdream Monksdream 8 meses hace
EVAX under $5
👍️0
Monksdream Monksdream 11 meses hace
EVAX new 52 week low
👍️0
Awl416 Awl416 11 meses hace
Evaxion Announces Successful Completion of the Initial Phases of Ongoing Vaccine Collaboration with MSD
👍️0
BooDog BooDog 12 meses hace
Halted. Offering exercise @ $4???? no way, that'll get reoffered for lower imo.

https://www.globenewswire.com/news-release/2024/02/01/2822093/0/en/Evaxion-Biotech-Announces-Pricing-of-15-Million-Public-Offering.html
👍️0
da_stock_analyst da_stock_analyst 1 año hace
#EVAX 🔥 low float crazy stock! Can run big tomorrow! $evax
👍️0
subslover subslover 1 año hace
Thanks! 14.77 is INSANITY! Hey, look what is going on with AFIB. No news since November. I used to trade that one in the past and banked several times
👍️0
TheFinalCD TheFinalCD 1 año hace
nice trading, you got ,more than me

this POS hit 14.77 ah

got out at $12 and we make a nice living on buying and selling these POS Companies! :)))))
👍️0
Awl416 Awl416 1 año hace
LOL
👍️0
rdeano221 rdeano221 1 año hace
$EVAX Jan. 24, 2024, 07:32 AM
InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Evaxion Biotech (NASDAQ:EVAX) stock is on the rise Wednesday after the company revealed a stake held by Merck (NYSE:MRK).

A filing with the Securities and Exchange Commission (SEC) notes that Merck now holds an 11.4% stake in Evaxion Biotech. That comes from the 2,297,884 shares of EVAX and warrants to acquire another 2,297,704 shares that the company owns.

The stake that Merck holds is based on the 40,204,700 shares outstanding as of Jan. 11, 2024. That comes from 37,906,996 shares of MRK stock outstanding and 2,297,704 shares issuable upon the exercise of warrants.
👍️0
subslover subslover 1 año hace
It's amazing what a couple of keywords can do! Excellent IR work. I got out at $12 and we make a nice living on buying and selling these POS Companies! :)))))
👍️0
TheFinalCD TheFinalCD 1 año hace
$13'S ON THAT NEWS, POST RS PLAYS CAN BE WILD

I BOUGHT AS LOW AS 7.77 BUY DIDNT HOLD


WHERE DID YOU SELL?

Message in reply to:
LOL. Looks fake but I'll take it, man! :)
👍️0
subslover subslover 1 año hace
$11.93 and halted again
👍️0
TheFinalCD TheFinalCD 1 año hace
OF COURSE 9.72 HALTED UP

OPEN $10+
👍️0
subslover subslover 1 año hace
Hey! its all about making $$$$ :)
👍️0
TheFinalCD TheFinalCD 1 año hace
9.50 WAS MY HIGHEST SELL

NOW 8.50
👍️0
TheFinalCD TheFinalCD 1 año hace
I SEE IT NOW... 1-10 RS

WHAT HAPPENED ON THE 22ND FOR EVAX TO DROP TO 3.36? -45%


Jan 23 2024 4.99 1.33 36.29% 5.55 5.57 4.15 1,225,974
Jan 22 2024 3.6612 -3.04 -45.36% 6.94 6.94 3.36 212,44
👍️0
TheFinalCD TheFinalCD 1 año hace
WHAT HAPPENED ON THE 22ND FOR NVAX TO DROP TO 3.36? -45%


Jan 23 2024 4.99 1.33 36.29% 5.55 5.57 4.15 1,225,974
Jan 22 2024 3.6612 -3.04 -45.36% 6.94 6.94 3.36 212,44
👍️0
TheFinalCD TheFinalCD 1 año hace
;LOOKS LIKE $10+ COMING SOON
👍️0
subslover subslover 1 año hace
Yeah, but well-written fluff. Took a position last night,not gonna hold it long
👍️0
TheFinalCD TheFinalCD 1 año hace
EVAX 8.88 you mean fluff?
👍️0
subslover subslover 1 año hace
LOL. Looks fake but I'll take it, man! :)
👍️0
subslover subslover 1 año hace
LOL. Looks fake but I'll take it, man! :)
👍️0
TheFinalCD TheFinalCD 1 año hace
EVAX 7.77 Evaxion to Develop Tailored Novel Cancer Vaccines Based upon a New Untapped Source of AI-Discovered Targets
https://www.globenewswire.com/news-release/2024/01/24/2815320/0/en/Evaxion-to-Develop-Tailored-Novel-Cancer-Vaccines-Based-upon-a-New-Untapped-Source-of-AI-Discovered-Targets.html

https://finviz.com/quote.ashx?t=EVAX&p=d#google_vignette
👍️0
Awl416 Awl416 1 año hace
LOL

Evaxion to Develop Tailored Novel Cancer Vaccines Based upon a New Untapped Source of AI-Discovered Targets
👍️0
subslover subslover 1 año hace
NEWS
Evaxion Announces Completion of ADS Ratio Change
COPENHAGEN, Denmark, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today announced that the Company’s previously disclosed change to its ratio of its American Depositary Shares (“ADSs”) to its ordinary shares, DKK 1 nominal value (the “ADS Ratio”), has been made effective. The ratio has changed from one (1) ADS representing one (1) ordinary share to a new ADS Ratio of one (1) ADS representing ten (10) ordinary shares (the “ADS Ratio Change”). The ADS Ratio Change became effective on January 22, 2024 (the “Effective Date”).

For the Company's ADS holders, the change in the ADS Ratio has the same effect as a one-for-ten reverse ADS split and is intended to further support the liquidity in the Company’s ADSs and to enable the Company to regain compliance with the Nasdaq minimum bid price requirement. The exchange of one (1) new ADS for every ten (10) then-held (existing) ADSs occurred automatically on the Effective Date, with the then-held ADSs being cancelled and new ADSs being issued by The Bank of New York Mellon, the depositary bank (the “Depositary”). Registered holders of the Company’s ADSs held in certificated form were required on a mandatory basis to surrender their certificated ADSs to the Depositary for cancellation and received one (1) new ADS in exchange for every ten (10) existing ADSs then-held. Holders of uncertificated ADSs in the Direct Registration System (DRS) and The Depository Trust Company (DTC) had their ADSs cancelled and automatically exchanged, receiving one (1) new ADS for every ten (10) existing ADS then-held. The Company’s ADSs continue to be traded on The Nasdaq Capital Market under the ticker symbol “EVAX”.

The ADS Ratio Change affects all shareholders uniformly and will not alter any shareholder’s percentage interest in the Company’s equity, except to the extent that the ratio change would have resulted in a shareholder owning fractional ADSs. No fractional new ADSs were issued in connection with the change in the ADS Ratio. Instead, fractional entitlements to new ADSs will be aggregated and sold by the Depositary, and the net cash proceeds from the sale of the fractional ADS entitlements (after deduction of fees, taxes and expenses) will be distributed to the applicable ADS holders by the Depositary.

As a result of the ADS Ratio Change, the ADS trading price is expected to increase proportionally, although the Company can give no assurance that the ADS trading price after the ADS Ratio Change will be proportionally equal to or greater than the previous ADS trading price prior to the change or that the Ratio Change will have any effect on the liquidity in the Company’s ADSs.
👍️0
Awl416 Awl416 1 año hace
Some would say unnecessary move AH

Of course they just did a RS too
👍️0
Disquisition Disquisition 1 año hace
INDESCRIBABLE DUMPING
👍️0
Renee Renee 1 año hace
EVAX: planned one for 10 reverse split for Jan. 22,2024:

https://hedgefollow.com/upcoming-stock-splits.php
👍️0
BooDog BooDog 1 año hace
Today's range $0.57 - $0.77
👍️0
BooDog BooDog 1 año hace
Evaxion to Unveil Potentially Groundbreaking AI-Immunology™ Precision Cancer Vaccine Concept

Proof of Concept – Evaxion’s AI-Immunology™ platform demonstrates success in designing precision cancer vaccines in hematological cancers by targeting a novel class of antigens
Broad Applicability – The vaccine concept holds tremendous potential, offering broad applicability and promising benefits for patients with hematological malignancies

COPENHAGEN, Denmark, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, proudly announces the presentation of its novel precision vaccine concept at the 65th American Society of Hematology (ASH) Annual Meeting, taking place in San Diego, California, from December 9-12, 2023.

https://ih.advfn.com/stock-market/NASDAQ/evaxion-biotech-as-EVAX/stock-news/92667300/form-6-k-report-of-foreign-issuer-rules-13a-16
👍️0
BooDog BooDog 1 año hace
NEWS: Evaxion Announces Encouraging Initial Phase 2 Clinical Data on Its Personalized Cancer Vaccine EVX-01
October 31, 2023 11:15 ET
| Source: Evaxion Biotech


https://www.globenewswire.com/news-release/2023/10/31/2770437/0/en/Evaxion-Announces-Encouraging-Initial-Phase-2-Clinical-Data-on-Its-Personalized-Cancer-Vaccine-EVX-01.html
👍️0
BooDog BooDog 1 año hace
High $1.10.
👍️0
BooDog BooDog 1 año hace
Maybe this time the push actually happens!!
👍️0

Su Consulta Reciente

Delayed Upgrade Clock